APLN and in situ carcinoma: As we mentioned above, we believe quantification of Apelin and Vaspin in CIS patients can help strongly and quickly evaluate the possibility of HT and timely intervene with the patients, which can offer reliable guarantee to the safety of CIS patients after thrombolysis in the future.